Loading…
Rockwell Medical, Inc. is projected to decline to $5.52 by 2027, a -4% move from its current price of $5.77. RMTI is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $5.54 | $5.77 | $6.00 | +0.07% |
| Jul 13 | $5.46 | $5.77 | $6.11 | +0.14% |
| Jul 14 | $5.39 | $5.78 | $6.19 | +0.21% |
| Jul 15 | $5.34 | $5.78 | $6.26 | +0.28% |
| Jul 16 | $5.29 | $5.78 | $6.33 | +0.35% |
| Jul 17 | $5.25 | $5.79 | $6.38 | +0.41% |
| Jul 18 | $5.21 | $5.79 | $6.44 | +0.48% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $5.21 | $5.79 | $6.44 | +0.48% |
| Week 2 | $5.01 | $5.82 | $6.76 | +0.97% |
| Week 3 | $4.87 | $5.85 | $7.02 | +1.46% |
| Week 4 | $4.76 | $5.88 | $7.26 | +1.95% |
| Week 5 | $4.66 | $5.91 | $7.48 | +2.44% |
| Week 6 | $4.58 | $5.93 | $7.69 | +2.94% |
| Week 7 | $4.51 | $5.96 | $7.89 | +3.44% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Rockwell Medical, Inc. is a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide.
Its portfolio includes citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterilyte bicarbonate concentrate, bicarbonate cartridges, and dry acid concentrate mixer, as well as ancillary products, including 5% acetic acid, cleaner, citric acid descaler, water softener salt pellets, and other supplies used by hemodialysis providers.
The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. The company was formerly known as Rockwell Medical Technologies, Inc. and changed its name to Rockwell Medical, Inc.
in June 2012. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.
Rockwell Medical, Inc. is currently trading with a current price of $5.63 and a market cap of $22.22M, ranking 4863 by market size.
The stock’s near-term outlook is reflected in the 30-day forecast, which places mixed signals on price action but highlights a defined range and key levels to watch. Long-run projections show a path from flat to modest gains in the near term toward stronger bullish momentum in the outer years, with substantial upside potential in the 2040s and 2050s according to the provided forecast data.
A major floor 89.8% below — a decisive break under it would weaken the trend.
The nearest floor, 10.0% below — buyers have tended to step in here.
The nearest ceiling, 31.8% above — a clean break opens room to run.
A major ceiling 66.7% above — clearing it would confirm fresh momentum.
Key RMTI support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of RMTI market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.74 | Buy | $5.48 | Buy |
| MA 10 | $4.62 | Buy | $4.66 | Buy |
| MA 20 | $2.64 | Buy | $3.41 | Buy |
| MA 50 | $1.52 | Buy | $2.09 | Buy |
| MA 100 | $1.23 | Buy | $1.54 | Buy |
| MA 200 | $1.13 | Buy | $1.32 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 81.10 | Sell |
| Stoch RSI (14) | 76.36 | Neutral |
| CCI (20) | 83.10 | Neutral |
| Williams %R (14) | -8.89 | Info |
| MACD (12,26,9) | 0.41 | Buy |
| ROC (12) | 737.31 | Buy |
| Bollinger %B (20,2) | 0.80 | Neutral |
| Stochastic %K (14) | 91.11 | Sell |
| TRIX (15) | 11.60 | Buy |
| Awesome (5,34) | 3.89 | Buy |
| Ultimate (7,14,28) | 66.28 | Neutral |
| Momentum (10) | 4.96 | Buy |
| Aroon Osc (25) | 20.00 | Buy |
| Hull MA (9) | 6.10 | Sell |
| ADX (14) | 48.87 | Buy |
| ATR (14) | 0.33 | Info |
30-day technical picture:
- Sentiment: BEARISH
- RSI(14): 40
- SMA50: $7.26
- SMA200: $9.37
- Support: $5.19
- Resistance: $7.60
- 30-day range: $4.27 to $7.42
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $5.19 | $5.77 | $8.25 | 0% | Neutral | |
| $4.21 | $5.52 | $7.77 | -4% | Neutral | |
| $3.97 | $5.44 | $8.06 | -6% | Neutral | |
| $5.11 | $7.26 | $11.17 | +26% | Bullish | |
| $5.54 | $8.13 | $12.93 | +41% | Bullish | |
| $5.48 | $8.29 | $13.57 | +44% | Bullish | |
| $5.11 | $7.95 | $13.34 | +38% | Bullish | |
| $4.78 | $7.63 | $13.10 | +32% | Bullish | |
| $4.93 | $8.08 | $14.16 | +40% | Bullish | |
| $5.35 | $8.97 | $16.04 | +56% | Bullish | |
| $5.37 | $10.11 | $19.56 | +75% | Bullish | |
| $11.25 | $25.00 | $54.20 | +334% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $5.19 | $5.77 | $6.80 | +0.00% |
| August 2026 | $4.88 | $5.84 | $7.22 | +1.26% |
| September 2026 | $5.08 | $6.14 | $7.71 | +5.17% |
| October 2026 | $4.98 | $6.07 | $7.73 | -1.11% |
| November 2026 | $4.94 | $6.06 | $7.80 | -0.16% |
| December 2026 | $5.13 | $6.34 | $8.25 | +4.65% |
Click any year to see its month-by-month RMTI forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, RMTI is projected to trade between $5.19 and $8.25, averaging $5.77 — a potential gain of 0% from today's $5.77. A consolidation phase looks the most probable path here.
Rockwell Medical, Inc.'s 2027 outlook centres on $5.52, within a $4.21 to $7.77 range. That is -4% versus the projected 2026 average. That marks a -4% change versus current levels. Price action looks broadly range-bound.
By 2028, RMTI could reach as high as $8.06, with a base case around $5.44 and support toward $3.97 — roughly -6% from $5.77. A consolidation phase looks the most probable path here.
Expect RMTI to range from $5.11 to $11.17 through 2029. The $7.26 average target implies a +26% move from current prices. That is up +33% on the projected 2028 average. Momentum favours further upside here.
The RMTI price prediction for 2030 points to an average of $8.13 (low $5.54, high $12.93) — a potential gain of +41% on today's $5.77. Buyers look set to stay in control over this stretch.
In 2031, RMTI is projected to trade between $5.48 and $13.57, averaging $8.29 — a potential gain of +44% from today's $5.77. That is up +2% on the projected 2030 average. Momentum favours further upside here.
Rockwell Medical, Inc.'s 2032 outlook centres on $7.95, within a $5.11 to $13.34 range. That is -4% versus the projected 2031 average. That marks a +38% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, RMTI could reach as high as $13.10, with a base case around $7.63 and support toward $4.78 — roughly +32% from $5.77. Momentum favours further upside here.
Expect RMTI to range from $4.93 to $14.16 through 2034. The $8.08 average target implies a +40% move from current prices. That is up +6% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The RMTI price prediction for 2035 points to an average of $8.97 (low $5.35, high $16.04) — a potential gain of +56% on today's $5.77. Momentum favours further upside here.
In 2040, RMTI is projected to trade between $5.37 and $19.56, averaging $10.11 — a potential gain of +75% from today's $5.77. That is up +13% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Rockwell Medical, Inc.'s 2050 outlook centres on $25.00, within a $11.25 to $54.20 range. That is up +147% on the projected 2040 average. That marks a +334% change versus current levels. Momentum favours further upside here.
Investing $1,000 in RMTI today (≈ 173.460538 RMTI) could be worth
$4,336.9
+$3,336.9 (+334%) by 2050 · US Dollar
Based on the average projected RMTI price of $25 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in RMTIwould be worth at today's price.
$1,000 invested in RMTI on Jul 10, 2025 (≈ 775.193821 RMTI) would be worth
$4,468.99
+$3,468.99 (+346.9%) today · 4.47× · US Dollar
Based on a RMTI entry price of $1.29 vs. today's $5.77.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.54 | $1,040.61 | +4.1% |
| 1 month ago | $0.67 | $8,604.48 | +760.4% |
| 3 months ago | $0.91 | $6,335.16 | +533.5% |
| 6 months ago | $1 | $5,765 | +476.5% |
| 1 year ago | $1.29 | $4,468.99 | +346.9% |
| All time (5.0y) ago | $9.13 | $631.43 | -36.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our RMTI forecast.
Our base-case forecast reaches $12.00 around 2050.
Implied market cap at $12.00: $47.36M
Long-term forecast interpretation:
- 2026: avg $5.63 with min $5.19 and max $8.14; ROI 0%; sentiment NEUTRAL. - 2027: avg $5.33 with min $4.03 and max $7.56; ROI -5.4%; sentiment NEUTRAL. - 2028: avg $5.24 with min $3.79 and max $7.84; ROI -6.8%; sentiment NEUTRAL.
- 2029: avg $7.09 with min $4.93 and max $11.04; ROI 25.9%; sentiment BULLISH. - 2030: avg $7.91 with min $5.32 and max $12.73; ROI 40.4%; sentiment BULLISH. - 2031: avg $8.07 with min $5.26 and max $13.39; ROI 43.4%; sentiment BULLISH.
- 2032: avg $7.74 with min $4.90 and max $13.17; ROI 37.4%; sentiment BULLISH. - 2033: avg $7.34 with min $4.52 and max $12.79; ROI 30.4%; sentiment BULLISH. - 2034: avg $7.79 with min $4.67 and max $13.88; ROI 38.5%; sentiment BULLISH.
- 2035: avg $8.67 with min $5.06 and max $15.74; ROI 54%; sentiment BULLISH. - 2040: avg $9.69 with min $5.00 and max $19.10; ROI 72.2%; sentiment BULLISH. - 2050: avg $24.30 with min $10.94 and max $53.80; ROI 331.7%; sentiment BULLISH.
The trajectory moves from subdued to increasingly bullish over the long horizon, with the strongest upside indicated in 2050. These figures are estimates and not guarantees, and actual results can differ based on market conditions and company performance.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $7.91, a minimum of $5.32, and a maximum of $12.73, with an estimated ROI of 40.4% and a bullish sentiment.
Forecasts show a bullish trajectory from 2029 onward with higher average prices and ROI (e.g., 2029 avg $7.09, ROI 25.9%; 2030 avg $7.91, ROI 40.4%; 2050 avg $24.30, ROI 331.7%), though earlier years like 2027 and 2028 forecast negative ROI (-5.4% and -6.8%), so outcomes are uncertain.
Yes, the 2050 forecast lists a max of $53.80 with an average of $24.30 and ROI of 331.7%, indicating substantial upside under the forecast scenario.
The current price is $5.63 and the market cap is $22.22M.
The 30-day range is from $4.27 to $7.42.
Rockwell Medical, Inc. Community Discussion
0Share your Rockwell Medical, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.